eBioMedicine is leaving this platform but joining others ⤵️
You can now find us on
Bluesky 👉 @ebiomedicine.bsky.social
LinkedIn 👉https://t.co/qyK5OpG5kf
🌐 And, of course, online at https://t.co/uFRKSfqHSv.
Follow us!
Why do some people avoid COVID-19 infection despite high levels of exposure? We discovered an ultra-early, interferon-associated immune response in 'resistant' individuals that might halt the virus before it gains a foothold https://t.co/djlWx5hS5E
Using disease information from routine clinical radiology reports enables accurate anomaly detection without requiring manual annotations @synapse_r@IVR57958121 Read #openaccess now 👇https://t.co/TcwDSOZYCv
New from @eBioMedicine - LJI researchers investigate #COVID19 immune responses with new mouse models:
"Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice" https://t.co/4bZRmCEvvG
Biomarkers of neurodegeneration: the global challenges and benefits are are explored in a new @LancetLongevity–@eBioMedicine Series ⤵️
https://t.co/QCi7XvcUlT
These biomarkers have the potential to enhance clinical research and diagnosis, but their use is highly context-specific and patients' preferences and needs must be prioritised.
The @eBioMedicine and @LancetLongevity Series BioMarkers of Neurogeneration: https://t.co/Q8lvRq9R5V
Introduction by Series lead Juan Fortea - Context matters: the evolving use of biomarkers in Alzheimer's disease care https://t.co/WamZeQHQvs
Podcast: https://t.co/C2XCvjp3HQ
Researchers at #UniLeipzig and @ChariteBerlin have developed an approach using #AI to compare the molecular mechanisms of #COVID-19 disease in humans and animals. Their findings have now been published in @eBioMedicine:
https://t.co/v31JdoGb0V
Post-Doc Appreciation Week =@rharewood's work in @eBioMedicine
The largest study of its kind links dysregulated lipid metabolism to #BowelCancer risk
⬆️levels of 2 lipids associated with⬇️#BowelCancer risk showing how diet lifestyle & metabolism may influence #CancerDevelopment
Researchers @UCLeye have revealed tissue-specific somatic instability underlies a common age-related cause of visual loss. Translationally relevant findings for repeat-expansion mediated diseases #OpticalGenomeMapping#RepeatExpansions
Read #openaccess👇
https://t.co/lqd80phKfb
🔊 Prof. Torben Hansen from the Novo Nordisk Foundation Centre for Basic Metabolic Research, @UCPH_Research, speaks to Dr Gita Thapaliya about the interplay between birth weight and obesity in determining childhood and adolescent cardiometabolic risks 👇
https://t.co/QlcgDcbggd
In a recent @eBioMedicine release, Dr. Esther Lim & collaborators provide a framework to study treatment response within distinct #melanoma cell states.
📰: https://t.co/sutOP8z0ja
Paper Alert!
Our new work shows collagen IV variants act by collagen IV deficiency, hypertrophic remodeling and endothelium-dependent hyperpolarization in small vessel disease, a major cause of #stroke & #dementia@eBioMedicine@TheLancet@UofGSCMH
https://t.co/x6BRIGBTPD
a 🧵
Our new paper with Tom Russo’s lab is out in @eBioMedicine We took out individual genes, combinations, or the whole virulence plasmid to measure their relative contribution in K. pneumoniae hypervirulence #hvkp@KlebClub https://t.co/LSmJxJBKN4
To preprocess or not to preprocess your #EEG 🔮when using #ML? 💫An enhanced version of our latest work at @Roche is now published in @eBioMedicine https://t.co/5Agp61gnWD #DeepDive#Thread 🧵in next post 👉👉🏾👉🏻
Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continue publishing some of the best science for better lives. This is as much your achievement!
We are an internationally trusted source for translational biomedical research. While a partial measurement of our impact, we are pleased to share our Impact Factor of 9·7 and CiteScore of 17·7.
https://t.co/s4a8CQUuiY